PI4KIIIbeta inhibitors (Gilead)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePI4KIIIbeta inhibitors (Gilead)

Drug Alias NameT-00127-HEV1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphatidylinositol 4-kinase beta inhibitors

TargetsPhosphatidylinositol 4-kinase beta

Therapy Area/IndicationsVirus Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsVirus Diseases

ATC CodeN/A